Layer displays the percentage of claims for prescription drugs among Medicare Part D beneficiaries that were for opioid drugs in 2018. Data is available by county, ZIP Code Tabulation Area (ZCTA) and by physician (address).
Opioid Use Disorder by County, 2019
This layer displays the percentage of Medicare beneficiaries with opioid use disorder in the latest report year (2019).
Prescription Drug Claims for Opioids by ZIP Code and County, 2019
Layer displays the percentage of claims for prescription drugs among Medicare Part D beneficiaries that were for opioid drugs in 2018. Data is available by county, ZIP Code Tabulation Area (ZCTA) and by physician (address).
Opioid Use Disorder by County, 2020
This layer displays the percentage of Medicare beneficiaries with opioid use disorder in the latest report year (2020).
Poisoning Mortality for 2016-20 by County
This layer displays poisoning mortality rates from the CDC’s National Vital Statistics System – Mortality database. Data are 5-year aggregates for 2016-20 and grouped by ICD-10 codes.
Opioid Overdose Mortality for 2016-20 by County
This layer displays opioid overdose mortality rates from the CDC’s National Vital Statistics System – Mortality database. Data are 5-year aggregates for 2016-20 and grouped by ICD-10 codes.
Physicians Authorized to Treat Opioid Dependency with Buprenorphine
This layer contains the location of practitioners authorized to treat opioid dependency with buprenorphine in the latest report year (2022).
Opioid Use Disorder by County, Medicare Population, 2021
This layer displays the percentage of Medicare beneficiaries with opioid use disorder in the latest report year (2020).
Prescription Drug Claims for Opioids by ZIP Code and County, 2019
Layer displays the percentage of claims for prescription drugs among Medicare Part D beneficiaries that were for opioid drugs in 2021. Data is available by county and ZIP Code Tabulation Area (ZCTA).
Physicians Authorized to Treat Opioid Dependency with Buprenorphine
This layer contains the location of practitioners authorized to treat opioid dependency with buprenorphine in the latest report year (2023).